buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottle (47335-737-86), b)100-count bottle (47335-737-88), c)500-count bottle (47335-737-13), Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical I
Check against the official notice below — it lists the full affected range.
Sun Pharmaceutical Industries Inc. is recalling bupropion hydrochloride extended-release tablets (150 mg) distributed nationwide in the USA because customers found a dark, gritty substance in bottles that was identified as activated carbon from the desiccant canister inside the bottle. The recall affects 9,804 bottles across three package sizes: 60-count bottles (lot numbers JKX5126A, JKX5127A, JKX5128A), 100-count bottles (lot numbers JKX5126B, JKX5128B), and 500-count bottles (lot numbers JKX5126C, JKX5127C, JKX5128C), all with expiration dates of 10/2022.
The source document does not specify what affected consumers should do regarding this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.
Reason for recall: Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle. Distribution: Nationwide in the USA Quantity: 9804 bottles Lot/code info: Lot #: a) JKX5126A, JKX5127A, JKX5128A, Exp 10/2022; b) JKX5126B , JKX5128B, Exp 10/2022; c)JKX5126C, JKX5127C, JKX5128C, Exp 10/2022;
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.